[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369691-105":59,"doc-detail-369691-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancer-incidence-in-people-with-hiv-in-italy-comparison-of-the-icona-cohort-with-general-population-data","Cancer incidence in people with HIV in Italy - Comparison of the ICONA COHORT with general population data","","The cancer risk of people with HIV (PWH) enrolled in Italy’s ICONA cohort with diagnosis between 01/1997 and 12/2023 is compared with the corresponding general population. Incident cancers were grouped by association with viral infections. Standardized incidence ratios (SIRs) compare observed versus expected cancers in PWH, while competing risks cumulative incidence curves and Gray’s test assess differences by gender and CD4+ T-cells at diagnosis. Among 17,298 PWH (79.1% males), 763 developed at least one incident cancer; PWH showed higher risk overall (SIR=1.6) with marked increases for virus-related cancers, while non-virus-related cancers were not more frequent. Lower CD4+ at cART initiation predicted the highest incidence, supporting prevention efforts including early cART, screening, and vaccination.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-incidence-in-people-with-hiv-in-italy-comparison-of-the-icona-cohort-with-general-population-data/369691/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-incidence-in-people-with-hiv-in-italy-comparison-of-the-icona-cohort-with-general-population-data/369691.png","ImageObject",300,407,{"name":92,"@type":93},"Cart","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was cancer incidence in people with HIV (PWH) compared to the general population?","Question",{"text":112,"@type":113},"Incident cancers among PWH were compared with expected counts from Italy’s general population using standardized incidence ratios (SIRs). Competing risks cumulative incidence curves and Gray’s test were used to compare incidence between groups with death as a competing risk.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which types of cancers occurred most frequently among PWH in the ICONA cohort?",{"text":117,"@type":113},"The most frequent cancers were Kaposi sarcoma (KS, N=204), non-Hodgkin lymphoma (NHL, N=127), and lung-trachea-bronchus cancer (N=66).",{"name":119,"@type":110,"acceptedAnswer":120},"How did CD4+ T-cell levels at cART initiation relate to cancer incidence?",{"text":121,"@type":113},"PWH with CD4+ \u003C200 cells/mm3 at cART initiation had the highest cancer incidence: 5% after 5 years, versus 3% for CD4+ 200–349 and 2% for CD4+ >350 (p\u003C0.001).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369691,1790219411,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","DOI: 10.1002/ijc.35493  \nRES EARCH A RTICLE  \nCa ncer Epidemiology  \nCancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data  \nPierluca Piselli 1  | Alessandro Tavelli 2,3 | Claudia Cimaglia 1 | Camilla Muccini 4 | Alessandra Bandera 5 | Giulia C. Marchetti 6 | Carlo Torti 7 | Valentina Mazzotta 1 |  \nLuca Pipitò 8 | Alessandro Caioli 1 | Enrico Girardi 1 | Andrea Antinori 1 | Diego Serraino 9 | Antonella d'Arminio Monforte 2 | Antonella Cingolani 7  | Icona Foundation Study Group  \n1Department of Epidemiology, Istituto Nazionale per le Malattie Infettive  \n“L. Spallanzani” IRCCS, Rome, Italy 2Fondazione ICONA, Milan, Italy  \n3National PhD Programme in One Health approaches to infectious diseases and life science research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy  \n4Infectious and Tropical Diseases Unit, IRCCSSan Raffaele, Milan, Italy  \n5Department of Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy  \n6ASST Santi Paolo e Carlo, Department of Health Science, University of Milan, Milan, Italy  \n7Department of Medical and Surgery Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy  \n8Department of Medicine, University of Palermo, Palermo, Italy  \n9Centro di Riferimento Oncologico (CRO), IRCCS, Aviano, Italy  \nCorrespondence  \nAntonella Cingolani, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica S. Cuore, Roma, Italy, L.go A. Gemelli, 8, 00167 Rome, Italy.  \nEmail: [antonella.cingolani@unicatt.it](antonella.cingolani@unicatt.it)  \nAbstract  \nThe cancer risk of people with HIV (PWH) enrolled in the Italian COhort of Naives to Antiretrovirals (ICONA) with HIV diagnosis occurred between 01/1997 and 12/2023 has been compared to that of the corresponding general population of Italy. Incident cancers were grouped according to their association with viral infections. Standardized incidence ratios (SIRs) were estimated as the ratio between the observed number of cancers among PWH and the expected ones among the general population. Competing risks cumulative incidence curves and Gray's test were used to compare incidence between groups (gender and CD4+ T-cells values at diagnosis) with death as a competing risk. Overall, 17,298 PWH (79 . 1% males) contributing to 133,851 person-years of follow-up were included; 763 (4 .4%) developed > = 1 incident cancers, the most frequent cancers being KS (N = 204), NHL (N = 127) and lungtrachea-bronchus (N = 66) . PWH were at 1 . 6-times higher risk for all cancers compared to the general population (SIR = 1. 6, 95% CI: 1 .5–1.8), with significantly increased SIR for almost all virus-related cancers, including KS (SIR = 145), NHL (SIR = 5.8), ICC (SIR = 6.0), anal cancer (SIR = 21.0) and Hodgkin lymphoma (SIR = 10.0) . Apart from lung cancer risk (SIR = 1.3), none of the non-virus-related cancers turned out to be more frequent among PWH. PWH with CD4 + \u003C200 cells/ mm3 at cART initiation showed the highest cancer incidence, 5% after 5 years, versus 3% for CD4+ 200–349 and 2% for CD4+ >350 (p \u003C .001) . These findings underscore the need to continue prevention efforts in PWH, including behavioral risk reduction, early cART initiation, screening, and vaccination.  \nAbbreviations: ADM, AIDS-defining malignancies; AIDS, acquired immune deficiency virus; cART, combined antiretroviral therapy; HCC, hepatocellular carcinoma; HL, Hodgkin lymphoma; ICC, invasive cervical cancer; ICONA, Italian Cohort of naïves to antiretrovirals; KM, Kaplan Meier; KS, Kaposi's sarcoma; NADM, non AIDS-defining malignancies; NHL, non-Hodgkin lymphoma; PWH, people living with HIV; SIR, standardized incidence ratio.  \nIcona Foundation Study Group details are provided in Appendix A.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, di","cbCaihC78U78iAsf","https://ap.wps.com/l/cbCaihC78U78iAsf","pdf",1721904,12,"English","# Abstract\n# Introduction\n## HIV and cancer risk\n## Virus-related and risk-factor–related cancers\n# Methods (as described in abstract)\n## Standardized incidence ratios and competing risks\n# Results (as described in abstract)\n## Overall cancer risk and site-specific patterns\n## CD4+ at cART initiation and cancer incidence\n# Conclusions and implications","[{\"question\":\"How was cancer incidence in people with HIV (PWH) compared to the general population?\",\"answer\":\"Incident cancers among PWH were compared with expected counts from Italy’s general population using standardized incidence ratios (SIRs). Competing risks cumulative incidence curves and Gray’s test were used to compare incidence between groups with death as a competing risk.\"},{\"question\":\"Which types of cancers occurred most frequently among PWH in the ICONA cohort?\",\"answer\":\"The most frequent cancers were Kaposi sarcoma (KS, N=204), non-Hodgkin lymphoma (NHL, N=127), and lung-trachea-bronchus cancer (N=66).\"},{\"question\":\"How did CD4+ T-cell levels at cART initiation relate to cancer incidence?\",\"answer\":\"PWH with CD4+ \\u003c200 cells/mm3 at cART initiation had the highest cancer incidence: 5% after 5 years, versus 3% for CD4+ 200–349 and 2% for CD4+ \\u003e350 (p\\u003c0.001).\"}]","Cancer incidence in people with HIV in Italy - Comparison of the ICONA COHORT with general population data | PDF",1790184111,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d203da07ba4ead8cda25ee7d12bad1be.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ff38fd80c8c2530472a2940520bc160.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53b4b08f17128a55d9b0e4b874fedb29.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb5d59746f7e09289f45f94c2dc1b569.webp",980,1287]